Phibro Animal Health Corporation
PAHC
$47.92
-$1.67-3.37%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 373.91M | 363.89M | 378.70M | 347.83M | 309.26M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 373.91M | 363.89M | 378.70M | 347.83M | 309.26M |
| Cost of Revenue | 240.42M | 242.99M | 270.15M | 237.75M | 205.76M |
| Gross Profit | 133.50M | 120.90M | 108.55M | 110.08M | 103.50M |
| SG&A Expenses | 78.50M | 72.05M | 68.07M | 70.46M | 67.08M |
| Depreciation & Amortization | -- | -- | 2.38M | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 318.92M | 315.04M | 340.59M | 308.21M | 272.84M |
| Operating Income | 54.99M | 48.85M | 38.10M | 39.61M | 36.42M |
| Income Before Tax | 36.43M | 36.27M | 23.85M | 29.69M | 4.84M |
| Income Tax Expenses | 8.97M | 9.74M | 6.62M | 8.81M | 1.65M |
| Earnings from Continuing Operations | 27.46M | 26.53M | 17.22M | 20.88M | 3.19M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 27.46M | 26.53M | 17.22M | 20.88M | 3.19M |
| EBIT | 54.99M | 48.85M | 38.10M | 39.61M | 36.42M |
| EBITDA | 67.88M | 61.68M | 49.09M | 52.23M | 48.00M |
| EPS Basic | 0.68 | 0.65 | 0.43 | 0.52 | 0.08 |
| Normalized Basic EPS | 0.63 | 0.52 | 0.44 | 0.55 | 0.24 |
| EPS Diluted | 0.67 | 0.65 | 0.43 | 0.51 | 0.08 |
| Normalized Diluted EPS | 0.63 | 0.52 | 0.43 | 0.55 | 0.24 |
| Average Basic Shares Outstanding | 40.53M | 40.53M | 40.50M | 40.52M | 40.50M |
| Average Diluted Shares Outstanding | 40.96M | 40.88M | 40.70M | 40.71M | 40.72M |
| Dividend Per Share | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 |
| Payout Ratio | 17.71% | 18.34% | 28.24% | 23.30% | 152.59% |